Insights

Strategic collaborations Eli Lilly is actively pursuing partnerships with AI-enabled biotech platforms (METiS TechBio) to develop tissue-specific lipid nanoparticles for RNA therapies, signaling a strong opportunity for contract research, platform licensing, or co-development discussions with AI and nanomedicine vendors.

AI driven delivery The focus on AI-enabled LNP discovery and optimization highlights a potential opening to offer specialized analytics, data integration, or simulation services that accelerate formulation design and tissue targeting for Lilly’s RNA-based programs.

Global expansion Recent Abu Dhabi Summit engagements and Mubadala Bio partnership indicate Lilly’s interest in expanding its life sciences footprint and capabilities in the UAE, suggesting sales opportunities in regional CROs, regulatory affairs support, manufacturing, and supply chain localization.

Commercial momentum Lilly’s revenue growth driven by flagship therapies positions the company to invest in enabling technologies, data platforms, and digital marketing solutions that optimize payer engagement, real-world evidence generation, and patient access programs.

Integrated tech stack Lilly’s use of enterprise tools (NetSuite, Oracle Eloqua, Epic Systems) indicates readiness for scalable, integrated solutions in CRM, ERP, and patient data management; opportunities exist for vendors offering interoperability, security, and analytics enhancements tailored to pharma workflows.

Similar companies to Eli Lilly and Company

Eli Lilly and Company Tech Stack

Eli Lilly and Company uses 8 technology products and services including Facebook Ads, Adobe Creative Cloud, Canva, and more. Explore Eli Lilly and Company's tech stack below.

Media & News

Eli Lilly and Company's Email Address Formats

Eli Lilly and Company uses at least 4 email formats:
Eli Lilly and Company Email FormatsExamplePercentage
Last_First@lilly.comDoe_John@lilly.com
56%
First_Last@lilly.comJohn_Doe@lilly.com
19%
First.Last@lilly.comJohn.Doe@lilly.com
14%
FLast@lilly.comJDoe@lilly.com
11%

Frequently Asked Questions

What is Eli Lilly and Company's phone number?

Minus sign iconPlus sign icon
You can contact Eli Lilly and Company's main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Eli Lilly and Company's official website and social media links?

Minus sign iconPlus sign icon
Eli Lilly and Company's official website is lilly.com and has social profiles on LinkedIn and Crunchbase.

How much revenue does Eli Lilly and Company generate?

Minus sign iconPlus sign icon
As of October 2026, Eli Lilly and Company's annual revenue is estimated to be $10B+.

What is Eli Lilly and Company's SIC code and NAICS code?

Minus sign iconPlus sign icon
Eli Lilly and Company's SIC code is 2835 - In Vitro and In Vivo Diagnostic Substances and NAICS code is 3254 - Pharmaceutical and Medicine Manufacturing.

How many employees does Eli Lilly and Company have currently?

Minus sign iconPlus sign icon
As of October 2026, Eli Lilly and Company has approximately 58K employees across 6 continents, including North America, Europe and Asia. Key team members include Cfo Lilly Cardiometabolic Health And Lilly Immunology: I. R., Coo, Lrl Project Management: J. K. and Cfo, France, Benelux & North West Africa: J. E. C. Explore Eli Lilly and Company's employee directory with LeadIQ.

What industry does Eli Lilly and Company belong to?

Minus sign iconPlus sign icon
Eli Lilly and Company operates in the Pharmaceutical Manufacturing industry.

What technology does Eli Lilly and Company use?

Minus sign iconPlus sign icon
Eli Lilly and Company's tech stack includes Facebook Ads, Adobe Creative Cloud, Canva, Google BigQuery, NetSuite, Epic Systems, BMC Remedy and Oracle Eloqua.

What is Eli Lilly and Company's email format?

Minus sign iconPlus sign icon
Eli Lilly and Company's email format typically follows the pattern of Last_First@lilly.com. Find more Eli Lilly and Company email formats with LeadIQ.

How much funding has Eli Lilly and Company raised to date?

Minus sign iconPlus sign icon
As of October 2026, Eli Lilly and Company has raised $6.5B in funding. The last funding round occurred on Feb 12, 2024 for $6.5M.
Eli Lilly and Company logo

Eli Lilly and Company

Pharmaceutical ManufacturingIndiana, United States10001+ Employees

Eli Lilly and Company is a pharmaceutical manufacturing firm headquartered in Indianapolis, Indiana (ZIP code 46285), with more than 10,001 employees. The company traces its origins to founder Colonel Eli Lilly, dating back nearly 150 years, and aims to translate science into medicines by applying biotechnology, chemistry, and genetic medicine. The organization uses biotechnology, chemistry, and genetic medicine to develop therapies intended to improve lives and address significant health challenges. In June 2026, Eli Lilly acquired 4E Therapeutics, a privately held neuroscience biotechnology company focused on non-opioid pain therapies, to expand its pipeline. In mid-2026 the company announced plans to invest more than $6 billion to build a next-generation pharmaceutical manufacturing facility in Greenbrier, Tennessee. The company's website is https://lilly.com.

Section iconCompany Overview

Phone number
Website
lilly.com
SIC Code
2835 - In Vitro and In Vivo Diagnostic Substances
NAICS Code
3254 - Pharmaceutical and Medicine Manufacturing
Employees
10001+

Section iconFunding & Financials

  • $6.5B

    Eli Lilly and Company has raised a total of $6.5B of funding over 1 rounds. Their latest funding round was raised on Feb 12, 2024 in the amount of $6.5M as a Post IPO Debt.

  • $10B+

    Eli Lilly and Company's revenue is estimated to be in the range of $10B+

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.